Characteristics | Number (%) |
---|---|
Median age (range) | 53.5 years (25~80) |
Sex | |
Male | 30 (60.0) |
Female | 20 (40.0) |
Ann Arbor stage | |
IE-IIE | 41 (82.0) |
IIIE-IVE | 9 (18.0) |
LDHa | |
Normal | 46 (92.0) |
Elevated | 4 (8.0) |
ECOGb Performance status | |
0–1 | 50 (100.0) |
2–4 | 0 (0.0) |
International prognostic index | |
0–1 | 40 (80.0) |
2 | 9 (18.0) |
3 | 1 (2.0) |
4 | 0 (0.0) |
Location of OAMLc | |
Eyelid | 7 (14.0) |
Lacrimal gland | 13 (26.0) |
Orbit | 30 (60.0) |
Laterality | |
Unilateral (right: left) | 40 (25:15) |
Bilateral | 10 |
Initial treatment | |
Chemotherapy | 37 (74.0) |
Radiation | 6 (12.0) |
Chemotherapy and radiation | 6 (12.0) |
Excision | 1 (2.0) |